Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome

被引:336
作者
Orlando, David A. [1 ]
Chen, Mei Wei [1 ]
Brown, Victoria E. [1 ]
Solanki, Snehakumari [1 ]
Choi, Yoon J. [1 ]
Olson, Eric R. [1 ]
Fritz, Christian C. [1 ]
Bradner, James E. [2 ,3 ]
Guenther, Matthew G. [1 ]
机构
[1] Syros Pharmaceut, Watertown, MA 02472 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
来源
CELL REPORTS | 2014年 / 9卷 / 03期
关键词
HISTONE H3; CHROMATIN; METHYLATION; GENE; REGULATORS; ROLES; CELLS; DOT1L;
D O I
10.1016/j.celrep.2014.10.018
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epigenomic profiling by chromatin immunoprecipitation coupled with massively parallel DNA sequencing (ChIP-seq) is a prevailing methodology used to investigate chromatin-based regulation in biological systems such as human disease, but the lack of an empirical methodology to enable normalization among experiments has limited the precision and usefulness of this technique. Here, we describe a method called ChIP with reference exogenous genome (ChIP-Rx) that allows one to perform genome-wide quantitative comparisons of histone modification status across cell populations using defined quantities of a reference epigenome. ChIP-Rx enables the discovery and quantification of dynamic epigenomic profiles across mammalian cells that would otherwise remain hidden using traditional normalization methods. We demonstrate the utility of this method for measuring epigenomic changes following chemical perturbations and show how reference normalization of ChIP-seq experiments enables the discovery of disease-relevant changes in histone modification occupancy.
引用
收藏
页码:1163 / 1170
页数:8
相关论文
共 41 条
[1]  
[Anonymous], 2010, CURR PROTOC MOL BIOL
[2]   The future of epigenetic therapy in solid tumours-lessons from the past [J].
Azad, Nilofer ;
Zahnow, Cynthia A. ;
Rudin, Charles M. ;
Baylin, Stephen B. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (05) :256-266
[3]   Emerging roles for chromatin as a signal integration and storage platform [J].
Badeaux, Aimee I. ;
Shi, Yang .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (04) :211-224
[4]   A computational pipeline for comparative ChIP-seq analyses [J].
Bardet, Anais F. ;
He, Qiye ;
Zeitlinger, Julia ;
Stark, Alexander .
NATURE PROTOCOLS, 2012, 7 (01) :45-61
[5]   High-resolution profiling of histone methylations in the human genome [J].
Barski, Artern ;
Cuddapah, Suresh ;
Cui, Kairong ;
Roh, Tae-Young ;
Schones, Dustin E. ;
Wang, Zhibin ;
Wei, Gang ;
Chepelev, Iouri ;
Zhao, Keji .
CELL, 2007, 129 (04) :823-837
[6]   Quantifying ChIP-seq data: a spiking method providing an internal reference for sample-to-sample normalization [J].
Bonhoure, Nicolas ;
Bounova, Gergana ;
Bernasconi, David ;
Praz, Viviane ;
Lammers, Fabienne ;
Canella, Donatella ;
Willis, Ian M. ;
Herr, Winship ;
Hernandez, Nouria ;
Delorenzi, Mauro .
GENOME RESEARCH, 2014, 24 (07) :1157-1168
[7]   Modification of Enhancer Chromatin: What, How, and Why? [J].
Calo, Eliezer ;
Wysocka, Joanna .
MOLECULAR CELL, 2013, 49 (05) :825-837
[8]   Potent inhibition of DOT1L as treatment of MLL-fusion leukemia [J].
Daigle, Scott R. ;
Olhava, Edward J. ;
Therkelsen, Carly A. ;
Basavapathruni, Aravind ;
Jin, Lei ;
Boriack-Sjodin, P. Ann ;
Allain, Christina J. ;
Klaus, Christine R. ;
Raimondi, Alejandra ;
Scott, Margaret Porter ;
Waters, Nigel J. ;
Chesworth, Richard ;
Moyer, Mikel P. ;
Copeland, Robert A. ;
Richon, Victoria M. ;
Pollock, Roy M. .
BLOOD, 2013, 122 (06) :1017-1025
[9]   Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor [J].
Daigle, Scott R. ;
Olhava, Edward J. ;
Therkelsen, Carly A. ;
Majer, Christina R. ;
Sneeringer, Christopher J. ;
Song, Jeffrey ;
Johnston, L. Danielle ;
Scott, Margaret Porter ;
Smith, Jesse J. ;
Xiao, Yonghong ;
Jin, Lei ;
Kuntz, Kevin W. ;
Chesworth, Richard ;
Moyer, Mike P. ;
Bernt, Kathrin M. ;
Tseng, Jen-Chieh ;
Kung, Andrew L. ;
Armstrong, Scott A. ;
Copeland, Robert A. ;
Richon, Victoria M. ;
Pollock, Roy M. .
CANCER CELL, 2011, 20 (01) :53-65
[10]   Cancer Epigenetics: From Mechanism to Therapy [J].
Dawson, Mark A. ;
Kouzarides, Tony .
CELL, 2012, 150 (01) :12-27